HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation.

Abstract
Recent study suggests that the proinflammatory and nociceptive effects of prostaglandin E(2) are mediated by prostanoid receptor subtype EP(4) and prostanoid EP(4) receptor may be a potential target for the treatment of inflammatory pain. Here we describe pharmacological characterization of a novel prostanoid EP(4) receptor antagonist, CJ-042,794 (4-{(1S)-1-[({5-chloro-2-[(4-fluorophenyl) oxy] phenyl} carbonyl) amino] ethyl} benzoic acid) in comparison with piroxicam (non-steroidal anti-inflammatory drug) or rofecoxib (cyclooxygenase-2 inhibitor). CJ-042,794 competitively antagonized cAMP accumulation with a pA(2) value of 8.7 in HEK293 cells overexpressing rat prostanoid EP(4) receptors. Orally administered CJ-042,794 dose-dependently inhibited carrageenan-induced mechanical hyperalgesia with an ED(50) value of 4.7 mg/kg (11 micromol/kg) and its maximal activity was somewhat less effective than that of 10 mg/kg piroxicam (30 micromol/kg p.o.). When CJ-042,794 and rofecoxib were administered to adjuvant-induced arthritis rats on Days 12-22 twice daily, both compounds reversed paw swelling to normal levels. These results suggest that a pharmacological blockade of the prostanoid EP(4) receptor may represent a new therapeutic strategy in signs and symptomatic relief of osteoarthritis and/or rheumatoid arthritis.
AuthorsAkio Murase, Takako Okumura, Ayano Sakakibara, Hiroko Tonai-Kachi, Kazunari Nakao, Junji Takada
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 580 Issue 1-2 Pg. 116-21 (Feb 02 2008) ISSN: 0014-2999 [Print] Netherlands
PMID18031725 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy) benzamido)ethyl) benzoic acid
  • Analgesics
  • Anti-Inflammatory Agents
  • Benzamides
  • Benzoates
  • Lactones
  • Ptger4 protein, rat
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP4 Subtype
  • Sulfones
  • rofecoxib
  • Piroxicam
  • Cyclic AMP
Topics
  • Administration, Oral
  • Analgesics (administration & dosage, pharmacology)
  • Animals
  • Anti-Inflammatory Agents (administration & dosage, pharmacology)
  • Benzamides
  • Benzoates (administration & dosage, pharmacology)
  • Cell Line
  • Cyclic AMP (metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • In Vitro Techniques
  • Inflammation (drug therapy)
  • Lactones (pharmacology)
  • Male
  • Pain (drug therapy)
  • Pain Measurement
  • Piroxicam (pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Receptors, Prostaglandin E (antagonists & inhibitors)
  • Receptors, Prostaglandin E, EP4 Subtype
  • Sulfones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: